openPR Logo
Press release

AI In Genomics Market on Track for Strong Growth, Estimated to Grow at 44.2% CAGR Through 2029

10-15-2025 12:05 PM CET | IT, New Media & Software

Press release from: The Business Research Company

AI In Genomics

AI In Genomics

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the AI In Genomics Market Through 2025?
The market size for AI in genomics has experienced rapid growth in the past few years. It is expected to increase from a worth of $1.06 billion in 2024 to $1.51 billion in 2025, with a compound annual growth rate (CAGR) of 41.9%. This significant growth during the historic period is due to factors like improvements in genomic sequencing, issues in data management, a surge in demand for personalized medicine, a better comprehension of diseases and their diagnosis, and advancements in drug discovery and development.

What's the Projected Size of the Global AI In Genomics Market by 2029?
The market of AI in genomics is predicted to experience a substantial rise in the upcoming years. The valuation is projected to reach $6.52 billion by 2029, expanding at a compound annual growth rate (CAGR) of 44.2%. The predicted market growth within the forecast period is largely attributed to factors such as the growth of genomic databases, superior genomic data security, utilization of AI for biomarker discovery, integration with other 'omics' data, and focus on patient education and empowerment. Some major trends coming to light during the forecast period encompass AI's role in cancer genomics, enhanced genomic imaging due to AI, AI-facilitated biomarker discovery, integrating genomic data across various healare systems, and the application of AI in functional genomics research.

View the full report here:
https://www.thebusinessresearchcompany.com/report/ai-in-genomics-global-market-report

Top Growth Drivers in the AI In Genomics Industry: What's Accelerating the Market?
The increasing use of AI is anticipated to fuel the expansion of the AI in genomics market. Artificial intelligence, a field that harnesses computer science and copious data sets to deal with challenges, encompasses machine learning and deep learning, often invoked when discussing artificial intelligence. AI in genomics contributes to the detection of genetic diseases, the prime kind of cancer, estimating the course of certain illnesses in patients, pinpointing disease-provoking genomic changes, and advancing the performance of gene modifying tools. Owing to these advantages, the demand for artificial intelligence in genomics is growing. For example, in May 2022, a report by US technology corporation, International Business Machines Corporation (IBM), disclosed a significant global adoption rate of AI increase to 35%, a four percent rise from the year before. Moreover, in May 2023, a report by the Australian government agency, Commonwealth Scientific and Industrial Research Organization (CSIRO), revealed that 68% of Australian businesses already utilize artificial intelligence technologies, and an extra 23% plan to adopt them in the coming year. Consequently, this rising adoption of AI is facilitating the growth of the AI in genomics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9612&type=smp

What Trends Will Shape the AI In Genomics Market Through 2029 and Beyond?
The significant rise of technological innovations is an emerging trend in the AI in genomics market, with leading businesses aiming at inventing advanced technological solutions to consolidate their market presence. Case in point, Genomic Vision, a biotech firm based in France that focuses on the creation of diagnostic solutions for genetic diseases and cancers, unveiled its FiberSmart, an AI-driven software in March 2023. This software facilitates the visualization and detailed analysis of lengthy DNA fibers. It could potentially revolutionize the approach towards diagnosing and treating genetic disorders. The main purpose of its inception was to enhance the accuracy and efficiency of diagnosis and treatment procedures for genetic diseases. It employs the technology to scrutinize massive data volumes, discovering patterns and insights that would be beyond human ability to detect independently.

What Are the Main Segments in the AI In Genomics Market?
The ai in genomicsmarket covered in this report is segmented -

1) By Component: Hardware, Software, Services
2) By Technology: Machine Learning, Computer Vision
3) By Functionality: Genome Sequencing, Gene Editing, Other Functionalities
4) By Application: Drug Discovery And Development, Precision Medicine, Diagnostics, Other Applications
5) By End-Use: Pharmaceutical And Biotech Companies, Healare Providers, Research Centers, Other End-Users

Subsegments:
1) By Hardware: Servers, Storage Devices, Networking Equipment
2) By Software: Data Analysis Software, Machine Learning Algorithms, Visualization Tools, Genomic Data Management Software
3) By Services: Consulting Services, Integration Services, Support And Maintenance, Data Analytics Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9612&type=smp

Which Top Companies are Driving Growth in the AI In Genomics Market?
Major companies operating in the AI in genomics market include International Business Machines Corporation, Microsoft Corp., NVIDIA Corporation, Deep Genomics Inc., BenevolentAI Ltd., Fabric Genomics Inc., Verge Genomic Inc., Freenome Holdings Inc., MolecularMatch Inc., SOPHiA GENETICS SA, Data4Cure Inc., PrecisionLife Ltd., Genoox Ltd., Lifebit Ltd., Empiric Logic Ltd., FDNA Inc., DNAnexus Inc., Engine Biosciences Pte Ltd., 4baseCare, Congenica Ltd., CytoReason Ltd., Emedgene Technologies LTD, Illumina Inc., Lifebit Biotech Ltd., Mendel.ai, Predictive Oncology Inc., Tempus Labs Inc., 10x Genomics Inc., Repositive Limited, Genedata AG, Global Gene Corp, Nference Inc., Bluebee Holding B.V., Genomenon Inc.

Which Regions Will Dominate the AI In Genomics Market Through 2029?
North America was the largest region in the AI in genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the AI in the genomics market report during the forecast period. The regions covered in the AI in genomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9612

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email:saumyas@tbrc.info
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release AI In Genomics Market on Track for Strong Growth, Estimated to Grow at 44.2% CAGR Through 2029 here

News-ID: 4225201 • Views:

More Releases from The Business Research Company

Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the Bivalve Market
Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the B …
The bivalve industry is positioned for steady advancement in the coming years, driven by growing consumer interest and evolving market dynamics. As demand increases across various sectors, from food to pharmaceuticals, the market is set to experience consistent expansion. Let's delve into the current market size, key players, emerging trends, and the main segments shaping the future of this industry. Projected Growth and Market Size of the Bivalve Industry by 2030
Analysis of Key Market Segments Influencing the Bio-Lactase Enzyme Market
Analysis of Key Market Segments Influencing the Bio-Lactase Enzyme Market
The bio-lactase enzyme market is poised for significant expansion over the coming years, driven by growing consumer demand and advancements in enzyme technology. This sector is evolving rapidly as manufacturers innovate to meet the increasing needs of various industries, particularly in food and nutrition. Projected Market Size and Growth of the Bio-Lactase Enzyme Market The bio-lactase enzyme market is anticipated to reach a valuation of $1.89 billion by 2030, showing
Market Trend Analysis: The Impact of Recent Innovations on the Beverage Packaging Market
Market Trend Analysis: The Impact of Recent Innovations on the Beverage Packagin …
The beverage packaging sector is on a promising growth trajectory, driven by rising sustainability efforts and technological advancements. As consumer preferences evolve and regulations tighten around plastic waste, this market is gearing up for substantial expansion. Let's delve into the expected market size, influential players, key trends, and segmentation details shaping the future of beverage packaging. Projected Market Size and Growth Prospects in the Beverage Packaging Market The beverage packaging
Analysis of Key Market Segments Influencing the Cold Brew Coffee Market
Analysis of Key Market Segments Influencing the Cold Brew Coffee Market
The cold brew coffee sector is rapidly evolving, attracting growing consumer interest due to its unique flavor profiles and convenience. As preferences shift toward healthier and sustainable beverage options, this market is positioned for substantial expansion over the coming years. Let's explore the current market value outlook, key players, emerging trends, and the primary segments contributing to this growth. Projected Growth and Market Size of the Cold Brew Coffee Industry

All 5 Releases


More Releases for Genomic

Genomic Cancer Testing Market Insights on the Impact of Genomic Profiling and Bi …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Genomic Cancer Testing Market - (By Test Type (Genomic Profiling Tests, Liquid Biopsy Tests, Companion Diagnostic Tests, Pharmacogenomic Tests, Hereditary Cancer Tests, Other specialized genomic tests), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Ovarian Cancer, Melanoma, Leukemia, Lymphoma, Other specific cancer types), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR),
Japan Genomic Medicine Market 2025 | Hospitals & clinics lead with 53% share, ad …
Leander, Texas and Tokyo, Japan - Nov.27.2025 As per DataM intelligence research report" Japan Genomic Medicine Market to expected to grow at High CAGR during forecast period 2024-2031." Personalized treatment approaches and advanced research investments are boosting genomic medicine adoption in Japan. Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/japan-genomic-medicine-market?Prasad Japan: Recent Industry Developments ✅ In November 2025, Takeda Pharmaceutical advanced genomic-guided therapies for rare hereditary diseases, improving precision in
Genomic and Epigenomic Profiling Market Development Driven by Investment in Biot …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Genomic & Epigenomic Profiling Market Size, Share & Trends Analysis Report, By Type (Genomic Profiling and Epigenomic Profiling), By Application (Clinical Diagnostics, Agriculture & Animal Research, and Drug Discovery & Development), By Technology (NGS, PCR-based, and Microarray), By End-use (Hospitals, Pharmaceuticals, and Research Institutes),-Market Outlook And Industry Analysis 2034" Genomic & Epigenomic Profiling Market Size is
Emerging Trends Influencing The Growth Of The Genomic Biomarker Market: Technolo …
The Genomic Biomarker Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. How Big Is the Genomic Biomarker Market Size Expected to Be by 2034? The size of the genomic biomarker market has witnessed swift expansion in the recent past. It is slated to expand from a
Genomic Biomarker Market Future Business Opportunities 2025-2032 | Liquid Genomi …
Latest Report, titled "Genomic Biomarker Market" Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis. The Genomic Biomarker market has been expanding significantly
Lipid-Nanoparticle Based Genomic Medicines Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Lipid-Nanoparticle Based Genomic Medicines Market - (By Type (Liposome-based Nanoparticles, Micelle-based Nanoparticles, Lipid-Coated Nanoparticles), By Application (Cancer Treatment, Infectious Diseases, Genetic Disorders, Cardiovascular Diseases, Others), By Therapeutic Payload (mRNA-based Therapeutics, siRNA-based Therapeutics, miRNA-based Therapeutics, Other Genomic Medicines), By End-User (Hospitals, Biopharmaceutical Companies, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the